Literature DB >> 35059118

Therapeutic Potential of Monoacylglycerol Lipase (MGL) Inhibitors as Treatment for Pain, Depression, Cancers, and Eye Conditions.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2021        PMID： 35059118      PMCID： PMC8762730          DOI： 10.1021/acsmedchemlett.1c00679

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Therapeutic potential of monoacylglycerol lipase inhibitors.

Authors:  Melinda M Mulvihill; Daniel K Nomura
Journal:  Life Sci       Date:  2012-11-08       Impact factor: 5.037

Review 2.  2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics.

Authors:  Gaurav Bedse; Mathew N Hill; Sachin Patel
Journal:  Biol Psychiatry       Date:  2020-03-17       Impact factor: 13.382

Review 3.  Targeting 2-arachidonoylglycerol signalling in the neurobiology and treatment of depression.

Authors:  Kennia M Silveira; Gregers Wegener; Sâmia R L Joca
Journal:  Basic Clin Pharmacol Toxicol       Date:  2021-05-17       Impact factor: 4.080

Review 4.  Endocannabinoids and striatal function: implications for addiction-related behaviours.

Authors:  Fabricio A Moreira; Bianca Jupp; David Belin; Jeffrey W Dalley
Journal:  Behav Pharmacol       Date:  2015-02       Impact factor: 2.293

Review 5.  Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders.

Authors:  Hui Deng; Weimin Li
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.